Health ❯ Healthcare ❯ Regulatory Approval

FDA

Drug Approval Process Biologics License Application Drug Development Medical Devices FluMist Approval Label Expansion Clinical Trials Drug Marketing Drug Safety Wegovy Tirzepatide Clinical Research Medical Innovations Medication Approval New Drug Approvals Biologics Licensing Agreement Medical Device Approval

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

The direct-to-consumer launch targets self-pay patients at a $299 starter price to expand choice.

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FTC Files to Block Edwards Lifesciences’ $945 Million JenaValve Acquisition

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure